Nuveen LLC bought a new position in Select Medical Holdings Corporation (NYSE:SEM - Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 726,556 shares of the health services provider's stock, valued at approximately $12,133,000. Nuveen LLC owned 0.57% of Select Medical as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC increased its position in shares of Select Medical by 217.4% in the 1st quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock valued at $109,000 after buying an additional 4,453 shares in the last quarter. Lazard Asset Management LLC increased its holdings in shares of Select Medical by 47.8% in the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock worth $130,000 after acquiring an additional 2,255 shares in the last quarter. Wealthquest Corp acquired a new stake in shares of Select Medical during the first quarter worth about $143,000. Quarry LP lifted its holdings in shares of Select Medical by 963.0% during the 4th quarter. Quarry LP now owns 9,078 shares of the health services provider's stock valued at $171,000 after purchasing an additional 8,224 shares in the last quarter. Finally, HBK Investments L P acquired a new position in shares of Select Medical in the 4th quarter valued at approximately $188,000. Institutional investors and hedge funds own 89.48% of the company's stock.
Select Medical Stock Up 1.6%
NYSE SEM traded up $0.21 during trading hours on Wednesday, hitting $13.05. 802,351 shares of the company traded hands, compared to its average volume of 1,279,772. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.15 and a current ratio of 1.15. The business's 50-day moving average is $13.93 and its 200-day moving average is $15.60. The stock has a market capitalization of $1.62 billion, a price-to-earnings ratio of 12.31, a P/E/G ratio of 0.52 and a beta of 1.25. Select Medical Holdings Corporation has a twelve month low of $11.65 and a twelve month high of $40.98.
Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $0.32 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.28 by $0.04. The company had revenue of $1.34 billion for the quarter, compared to analysts' expectations of $1.35 billion. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The business's revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.60 EPS. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Sell-side analysts anticipate that Select Medical Holdings Corporation will post 1.17 earnings per share for the current year.
Select Medical announced that its board has initiated a stock repurchase plan on Thursday, May 1st that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the health services provider to reacquire up to 42.6% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's leadership believes its shares are undervalued.
Select Medical Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, August 28th. Stockholders of record on Wednesday, August 13th will be issued a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, August 13th. Select Medical's dividend payout ratio is presently 23.58%.
Analysts Set New Price Targets
SEM has been the topic of a number of research reports. UBS Group reaffirmed a "neutral" rating and issued a $14.00 price target (down previously from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Royal Bank Of Canada cut their price objective on shares of Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 7th. Three analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $20.25.
Get Our Latest Analysis on Select Medical
Select Medical Company Profile
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Articles

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.